Guillermo Garcia-Manero, MD

Associate Editor

Dr. Garcia-Manero is Chief of the Section of Myelodysplastic Syndromes, Deputy Chair of Translational Research, and a Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center.

Articles by Guillermo Garcia-Manero, MD

Dr. Garcia-Manero Discusses the FDA Approval of Luspatercept

Guillermo Garcia-Manero, MDMeeting News | September 7, 2023

Guillermo Garcia-Manero, MD, joins Chadi Nabhan, MD, MBA, FACP, to discuss the COMMANDS trial at the SOHO Annual Meeting.

Back to the Future with 2023 SOHO President-elect Dr. Garcia-Manero

Guillermo Garcia-Manero, MDMyelodysplastic Syndromes | August 4, 2023

Guillermo Garcia-Manero, MD, the 2023 SOHO President-Elect, shares his hopes and goals for the coming years.

Dr. Garcia-Manero Weighs in on COMMANDS Trial Data Presented at EHA 2023

Guillermo Garcia-Manero, MDVideo Insights | June 9, 2023

Dr. Garcia-Manero presented results from the phase III COMMANDS trial during the 2023 ASCO Meeting.

Dr. Garcia-Manero on Targeting IRAK4 in MDS

Cecilia BrownMyelodysplastic Syndromes | June 4, 2023

Dr. Garcia-Manero presented information about a phase Ib study of IRAK1/4 inhibition at the 2023 ASCO Annual Meeting.

Guillermo Garcia-Manero, MD, on the Phase III COMMANDS Trial

Cecilia BrownMeeting News | June 3, 2023

In this video, Dr. Garcia-Manero discusses the study's primary endpoint, its implications for patients, and more.